Seeing Is Believing
Adagio Therapeutics's activity chart (see below) currently has 7 price targets and 16 ratings on display.
Analysts average stock forecasts to be materialized ratio is 61.9% with an average time for these price targets to be met of 18.14 days.
Most recent stock forecast was given by from MORGAN STANLEY on 17-May-2022. First documented stock forecast 31-Aug-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 07-Jan-2022
$3
$-0.48 (-13.79%)
4 years 1 months 23 days ago
(17-May-2022)
2/2 (100%)
$-0.06 (-1.96%)
16
Hold Since 13-May-2022
$5
$1.52 (43.68%)
4 years 1 months 27 days ago
(13-May-2022)
0/2 (0%)
$2.28 (83.82%)
Hold Since 23-Dec-2021
$10
$6.52 (187.36%)
4 years 6 months 12 days ago
(28-Dec-2021)
2/3 (66.67%)
$2.15 (27.39%)
46
Hold Since 16-Dec-2021
$40
4 years 6 months 24 days ago
(16-Dec-2021)
1/1 (100%)
$6.16 (18.20%)
3
What is ADGI (Adagio Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ADGI (Adagio Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ADGI (Adagio Therapeutics)?
Which analyst is the currently most bullish on ADGI (Adagio Therapeutics)?
Which analyst is the currently most reserved on ADGI (Adagio Therapeutics)?